Hyun Kim

Company: AOBiome Therapeutics
Job title: VP Clinical Operations
Seminars:
Efficacy & Safety of B244: A Live Topical Biotherapeutic, in Patients with Mild to Moderate Atopic Dermatitis & Associated Pruritus 9:00 am
Introducing B244, an ammonia oxidizing bacteria, as a topical spray investigational product Efficacy of B244 in itch relief and lesion control from a 547 patient Phase 2b study in mild to moderate atopic dermatitis Safety profile of B244Read more
day: Day One